117 related articles for article (PubMed ID: 34812529)
1. Identification of intrinsically disordered regions in hub genes of acute myeloid leukemia: A bioinformatics approach.
Ameri M; Alipour M; Madihi M; Nezafat N
Biotechnol Appl Biochem; 2022 Dec; 69(6):2304-2322. PubMed ID: 34812529
[TBL] [Abstract][Full Text] [Related]
2. Identification of six hub genes and analysis of their correlation with drug sensitivity in acute myeloid leukemia through bioinformatics.
Cai D; Liang J; Cai XD; Yang Y; Liu G; Zhou F; He D
Transl Cancer Res; 2021 Jan; 10(1):126-140. PubMed ID: 35116245
[TBL] [Abstract][Full Text] [Related]
3. Identification of Key Genes and Pathways Associated with RUNX1 Mutations in Acute Myeloid Leukemia Using Bioinformatics Analysis.
Zhu F; Huang R; Li J; Liao X; Huang Y; Lai Y
Med Sci Monit; 2018 Oct; 24():7100-7108. PubMed ID: 30289875
[TBL] [Abstract][Full Text] [Related]
4. Identification of the key genes and microRNAs in adult acute myeloid leukemia with FLT3 mutation by bioinformatics analysis.
Chen S; Chen Y; Zhu Z; Tan H; Lu J; Qin P; Xu L
Int J Med Sci; 2020; 17(9):1269-1280. PubMed ID: 32547322
[No Abstract] [Full Text] [Related]
5. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics Analysis Identifies Key Genes and Pathways in Acute Myeloid Leukemia Associated with DNMT3A Mutation.
Chen S; Chen Y; Lu J; Yuan D; He L; Tan H; Xu L
Biomed Res Int; 2020; 2020():9321630. PubMed ID: 33299888
[TBL] [Abstract][Full Text] [Related]
7. Identification of potential therapeutic target genes, key miRNAs and mechanisms in acute myeloid leukemia based on bioinformatics analysis.
Zhao Y; Zhang X; Zhao Y; Kong D; Qin F; Sun J; Dong Y
Med Oncol; 2015 May; 32(5):152. PubMed ID: 25832863
[TBL] [Abstract][Full Text] [Related]
8. Integrated Analysis of Hub Genes and Pathways In Esophageal Carcinoma Based on NCBI's Gene Expression Omnibus (GEO) Database: A Bioinformatics Analysis.
Yu-Jing T; Wen-Jing T; Biao T
Med Sci Monit; 2020 Aug; 26():e923934. PubMed ID: 32756534
[TBL] [Abstract][Full Text] [Related]
9. Identification of mast cells as a candidate significant target of immunotherapy for acute myeloid leukemia.
Jia M; Zhang H; Wang L; Zhao L; Fan S; Xi Y
Hematology; 2021 Dec; 26(1):284-294. PubMed ID: 33648435
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatics and Raman spectroscopy-based identification of key pathways and genes enabling differentiation between acute myeloid leukemia and T cell acute lymphoblastic leukemia.
Liang H; Kong X; Cao Z; Wang H; Liu E; Sun F; Qi J; Zhang Q; Zhou Y
Front Immunol; 2023; 14():1194353. PubMed ID: 37266435
[TBL] [Abstract][Full Text] [Related]
11. Identification of hub genes in thyroid carcinoma to predict prognosis by integrated bioinformatics analysis.
Pan Y; Wu L; He S; Wu J; Wang T; Zang H
Bioengineered; 2021 Dec; 12(1):2928-2940. PubMed ID: 34167437
[TBL] [Abstract][Full Text] [Related]
12. Identification of hub genes associated with adult acute myeloid leukemia progression through weighted gene co-expression network analysis.
Zhu R; Lin W; Tang L; Hu Y
Aging (Albany NY); 2021 Feb; 13(4):5686-5697. PubMed ID: 33592582
[TBL] [Abstract][Full Text] [Related]
13. Screening and
Fard AA; Rahimi H; Shams Z; Ghoraeian P
Microrna; 2022; 11(3):227-244. PubMed ID: 35546758
[TBL] [Abstract][Full Text] [Related]
14. Exploring Prognostic Biomarkers of Acute Myeloid Leukemia to Determine Its Most Effective Drugs from the FDA-Approved List through Molecular Docking and Dynamic Simulation.
Alom MM; Faruqe MO; Molla MKI; Rahman MM
Biomed Res Int; 2023; 2023():1946703. PubMed ID: 37359050
[TBL] [Abstract][Full Text] [Related]
15. Identification of prognostic genes in the acute myeloid leukemia immune microenvironment based on TCGA data analysis.
Yan H; Qu J; Cao W; Liu Y; Zheng G; Zhang E; Cai Z
Cancer Immunol Immunother; 2019 Dec; 68(12):1971-1978. PubMed ID: 31650199
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatics Analysis of Differentially Expressed Genes and Protein-Protein Interaction Networks Associated with Functional Pathways in Ulcerative Colitis.
Cao F; Cheng YS; Yu L; Xu YY; Wang Y
Med Sci Monit; 2021 Jan; 27():e927917. PubMed ID: 33462173
[TBL] [Abstract][Full Text] [Related]
17. Identification of key genes and pathways in castrate-resistant prostate cancer by integrated bioinformatics analysis.
Wu YP; Ke ZB; Lin F; Wen YA; Chen S; Li XD; Chen SH; Sun XL; Huang JB; Zheng QS; Xue XY; Wei Y; Xu N
Pathol Res Pract; 2020 Oct; 216(10):153109. PubMed ID: 32853947
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of inferior prognostic genes associated with immune signatures and chemotherapy outcome in acute myeloid leukemia.
Wang J; Hao JP; Uddin MN; Wu Y; Chen R; Li DF; Xiong DQ; Ding N; Yang JH; Ding XS
Aging (Albany NY); 2021 Jun; 13(12):16445-16470. PubMed ID: 34148032
[TBL] [Abstract][Full Text] [Related]
19. Gene network in pulmonary tuberculosis based on bioinformatic analysis.
Li L; Lv J; He Y; Wang Z
BMC Infect Dis; 2020 Aug; 20(1):612. PubMed ID: 32811479
[TBL] [Abstract][Full Text] [Related]
20. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
Gene; 2019 May; 698():9-18. PubMed ID: 30825595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
